Related Experiment Video
Updated: Jan 8, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
[Immunotherapy of cutaneous neoplasms]
1Onkodermatológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. ambrus.luca@oncol.hu.
Immune checkpoint inhibitors (ICIs) have transformed advanced skin cancer treatment, improving survival. This review covers current and future immunotherapy options for melanoma, SCC, BCC, and MCC.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Skin cancers are the most common malignancies globally.
- Advanced skin tumors historically lacked effective treatments.
- Recent advancements include immune checkpoint inhibitors (ICIs).
Purpose of the Study:
- To review current immunotherapy strategies for advanced skin cancers.
- To explore future directions in cutaneous cancer immunotherapy.
- To provide an overview of ICI mechanisms.
Main Methods:
- Literature review of immunotherapy in skin cancer management.
- Analysis of immune checkpoint inhibitors (CTLA-4, PD-1, PD-L1, LAG-3).
- Focus on malignant melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma.
Main Results:
- ICIs have revolutionized treatment for advanced skin cancers.
- Improved survival outcomes observed with ICI therapy.
- Current review details therapeutic opportunities and future potential.
Conclusions:
- Immunotherapy, particularly ICIs, offers significant advancements in treating advanced skin cancers.
- Future research directions are crucial for optimizing treatment.
- Understanding ICI mechanisms is key to managing cutaneous neoplasms.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...